Global Intravenous Immunoglobulin(IVIg) Therapy Market Growth 2026-2032
The global Intravenous Immunoglobulin(IVIg) Therapy market size is predicted to grow from US$ 19321 million in 2025 to US$ 32641 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.
Intravenous Immunoglobulin (IVIg) Therapy refers to the intravenous administration of highly purified polyclonal IgG antibodies derived from pooled human plasma, aimed at supplementing or modulating a patient?s immune function. It is widely used in the treatment of primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and certain inflammatory diseases. IVIg exerts its effects through multiple mechanisms, including pathogen neutralization, inhibition of autoantibodies, modulation of Fc receptor expression, and regulation of cytokine networks. As a foundational therapy in clinical immunology, IVIg therapy holds a significant position in critical care and chronic disease management due to its established safety profile and broad therapeutic coverage.In 2025, global Intravenous Immunoglobulin (IVIg) Therapy production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
The rising prevalence of immune-related diseases and improvements in diagnostic capabilities provide sustained growth momentum for IVIg therapy. Expansion into neurological and rare disease indications continues to broaden clinical applications. Accelerating population aging increases the number of patients with immune dysfunction-related conditions. Enhanced reimbursement coverage for major diseases improves patient accessibility. Technological advancements in purification processes and the introduction of high-concentration formulations enhance treatment efficiency and clinical acceptance, supporting steady market development.
IVIg therapy relies heavily on human plasma resources, which are inherently limited and sensitive to regulatory policies and public health events. The manufacturing process is complex, requiring stringent viral inactivation and purification standards, resulting in high production costs. In certain regions, price controls or centralized procurement policies may constrain profitability. Emerging biologics and targeted therapies are gaining traction in specific indications, creating competitive pressure. Strengthened rational-use regulations may also limit inappropriate utilization.
Downstream demand is concentrated in tertiary hospitals, neurology centers, immunology clinics, and rare disease treatment institutions. Treatment patterns are evolving from acute rescue use toward long-term maintenance and personalized management. High-concentration formulations and more convenient administration approaches are gaining attention, although intravenous infusion remains dominant in critical care settings. The adoption of multidisciplinary care models improves indication recognition and standardized usage. Enhanced patient education contributes to improved long-term treatment adherence.
The core raw material for IVIg therapy is plasma collected from healthy donors, with quality directly influencing product safety and stability. Plasma collection depends on compliant donation systems and strict screening procedures. Manufacturing involves separation reagents, chromatography resins, viral inactivation solvents, and sterile filling consumables. Cold chain logistics and batch release management ensure end-to-end quality control. As global competition for plasma resources intensifies, upstream supply security has become a key competitive barrier in the industry.
LP Information, Inc. (LPI) ' newest research report, the ?Intravenous Immunoglobulin(IVIg) Therapy Industry Forecast? looks at past sales and reviews total world Intravenous Immunoglobulin(IVIg) Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Intravenous Immunoglobulin(IVIg) Therapy sales for 2026 through 2032. With Intravenous Immunoglobulin(IVIg) Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Immunoglobulin(IVIg) Therapy industry.
This Insight Report provides a comprehensive analysis of the global Intravenous Immunoglobulin(IVIg) Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Immunoglobulin(IVIg) Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Intravenous Immunoglobulin(IVIg) Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Immunoglobulin(IVIg) Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Immunoglobulin(IVIg) Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin(IVIg) Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Intravenous Immunoglobulin(IVIg) Therapy market?
What factors are driving Intravenous Immunoglobulin(IVIg) Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous Immunoglobulin(IVIg) Therapy market opportunities vary by end market size?
How does Intravenous Immunoglobulin(IVIg) Therapy break out by Type, by Application?
Intravenous Immunoglobulin (IVIg) Therapy refers to the intravenous administration of highly purified polyclonal IgG antibodies derived from pooled human plasma, aimed at supplementing or modulating a patient?s immune function. It is widely used in the treatment of primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and certain inflammatory diseases. IVIg exerts its effects through multiple mechanisms, including pathogen neutralization, inhibition of autoantibodies, modulation of Fc receptor expression, and regulation of cytokine networks. As a foundational therapy in clinical immunology, IVIg therapy holds a significant position in critical care and chronic disease management due to its established safety profile and broad therapeutic coverage.In 2025, global Intravenous Immunoglobulin (IVIg) Therapy production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
The rising prevalence of immune-related diseases and improvements in diagnostic capabilities provide sustained growth momentum for IVIg therapy. Expansion into neurological and rare disease indications continues to broaden clinical applications. Accelerating population aging increases the number of patients with immune dysfunction-related conditions. Enhanced reimbursement coverage for major diseases improves patient accessibility. Technological advancements in purification processes and the introduction of high-concentration formulations enhance treatment efficiency and clinical acceptance, supporting steady market development.
IVIg therapy relies heavily on human plasma resources, which are inherently limited and sensitive to regulatory policies and public health events. The manufacturing process is complex, requiring stringent viral inactivation and purification standards, resulting in high production costs. In certain regions, price controls or centralized procurement policies may constrain profitability. Emerging biologics and targeted therapies are gaining traction in specific indications, creating competitive pressure. Strengthened rational-use regulations may also limit inappropriate utilization.
Downstream demand is concentrated in tertiary hospitals, neurology centers, immunology clinics, and rare disease treatment institutions. Treatment patterns are evolving from acute rescue use toward long-term maintenance and personalized management. High-concentration formulations and more convenient administration approaches are gaining attention, although intravenous infusion remains dominant in critical care settings. The adoption of multidisciplinary care models improves indication recognition and standardized usage. Enhanced patient education contributes to improved long-term treatment adherence.
The core raw material for IVIg therapy is plasma collected from healthy donors, with quality directly influencing product safety and stability. Plasma collection depends on compliant donation systems and strict screening procedures. Manufacturing involves separation reagents, chromatography resins, viral inactivation solvents, and sterile filling consumables. Cold chain logistics and batch release management ensure end-to-end quality control. As global competition for plasma resources intensifies, upstream supply security has become a key competitive barrier in the industry.
LP Information, Inc. (LPI) ' newest research report, the ?Intravenous Immunoglobulin(IVIg) Therapy Industry Forecast? looks at past sales and reviews total world Intravenous Immunoglobulin(IVIg) Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Intravenous Immunoglobulin(IVIg) Therapy sales for 2026 through 2032. With Intravenous Immunoglobulin(IVIg) Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Immunoglobulin(IVIg) Therapy industry.
This Insight Report provides a comprehensive analysis of the global Intravenous Immunoglobulin(IVIg) Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Immunoglobulin(IVIg) Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Intravenous Immunoglobulin(IVIg) Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Immunoglobulin(IVIg) Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Immunoglobulin(IVIg) Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin(IVIg) Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liquid
- Powder
- Low Concentration
- Medium Concentration
- High Concentration
- Acute Therapy
- Maintenance Therapy
- Critical Care
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
What is the 10-year outlook for the global Intravenous Immunoglobulin(IVIg) Therapy market?
What factors are driving Intravenous Immunoglobulin(IVIg) Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous Immunoglobulin(IVIg) Therapy market opportunities vary by end market size?
How does Intravenous Immunoglobulin(IVIg) Therapy break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Country/Region, 2021, 2025 & 2032
2.2 Intravenous Immunoglobulin(IVIg) Therapy Segment by Type
2.2.1 Liquid
2.2.2 Powder
2.2.3 Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
2.2.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
2.2.3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2021-2026)
2.3 Intravenous Immunoglobulin(IVIg) Therapy Segment by Product Concentration
2.3.1 Low Concentration
2.3.2 Medium Concentration
2.3.3 High Concentration
2.3.4 Intravenous Immunoglobulin(IVIg) Therapy Sales by Product Concentration
2.3.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Product Concentration (2021-2026)
2.3.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Product Concentration (2021-2026)
2.3.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Product Concentration (2021-2026)
2.4 Intravenous Immunoglobulin(IVIg) Therapy Segment by Treatment Setting
2.4.1 Acute Therapy
2.4.2 Maintenance Therapy
2.4.3 Critical Care
2.4.4 Intravenous Immunoglobulin(IVIg) Therapy Sales by Treatment Setting
2.4.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Treatment Setting (2021-2026)
2.4.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Treatment Setting (2021-2026)
2.4.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Treatment Setting (2021-2026)
2.5 Intravenous Immunoglobulin(IVIg) Therapy Segment by Application
2.5.1 Immunodeficiency
2.5.2 Autoimmune Disease
2.5.3 Acute Infection
2.5.4 Others
2.5.5 Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
2.5.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2021-2026)
2.5.5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Breakdown Data by Company
3.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Company (2021-2026)
3.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2021-2026)
3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2021-2026)
3.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2021-2026)
3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company
3.4 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.4 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.6 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
5 AMERICAS
5.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
5.1.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
5.1.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026)
5.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
5.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region
6.1.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026)
6.1.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2021-2026)
6.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
6.3 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous Immunoglobulin(IVIg) Therapy by Country
7.1.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
7.1.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026)
7.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
7.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.3 Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.4 Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
11.3 Intravenous Immunoglobulin(IVIg) Therapy Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
12.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Region
12.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Region (2027-2032)
12.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Type (2027-2032)
12.7 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.1.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.2.3 CSL Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.3.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.4.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.5.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.6.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.7.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.8.3 BPL Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.9.3 RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.10.3 CBPO Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.11.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Tiantan Bio
13.12.1 Tiantan Bio Company Information
13.12.2 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.12.3 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tiantan Bio Main Business Overview
13.12.5 Tiantan Bio Latest Developments
13.13 Shuanglin Bio
13.13.1 Shuanglin Bio Company Information
13.13.2 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.13.3 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shuanglin Bio Main Business Overview
13.13.5 Shuanglin Bio Latest Developments
13.14 Boya Bio
13.14.1 Boya Bio Company Information
13.14.2 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.14.3 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Boya Bio Main Business Overview
13.14.5 Boya Bio Latest Developments
13.15 Yuanda Shuyang
13.15.1 Yuanda Shuyang Company Information
13.15.2 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.15.3 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Yuanda Shuyang Main Business Overview
13.15.5 Yuanda Shuyang Latest Developments
13.16 Weiguang Bio
13.16.1 Weiguang Bio Company Information
13.16.2 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.16.3 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Weiguang Bio Main Business Overview
13.16.5 Weiguang Bio Latest Developments
13.17 Nanyue Bio
13.17.1 Nanyue Bio Company Information
13.17.2 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.17.3 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Nanyue Bio Main Business Overview
13.17.5 Nanyue Bio Latest Developments
13.18 KM Biologics
13.18.1 KM Biologics Company Information
13.18.2 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.18.3 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 KM Biologics Main Business Overview
13.18.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Country/Region, 2021, 2025 & 2032
2.2 Intravenous Immunoglobulin(IVIg) Therapy Segment by Type
2.2.1 Liquid
2.2.2 Powder
2.2.3 Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
2.2.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
2.2.3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2021-2026)
2.3 Intravenous Immunoglobulin(IVIg) Therapy Segment by Product Concentration
2.3.1 Low Concentration
2.3.2 Medium Concentration
2.3.3 High Concentration
2.3.4 Intravenous Immunoglobulin(IVIg) Therapy Sales by Product Concentration
2.3.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Product Concentration (2021-2026)
2.3.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Product Concentration (2021-2026)
2.3.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Product Concentration (2021-2026)
2.4 Intravenous Immunoglobulin(IVIg) Therapy Segment by Treatment Setting
2.4.1 Acute Therapy
2.4.2 Maintenance Therapy
2.4.3 Critical Care
2.4.4 Intravenous Immunoglobulin(IVIg) Therapy Sales by Treatment Setting
2.4.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Treatment Setting (2021-2026)
2.4.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Treatment Setting (2021-2026)
2.4.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Treatment Setting (2021-2026)
2.5 Intravenous Immunoglobulin(IVIg) Therapy Segment by Application
2.5.1 Immunodeficiency
2.5.2 Autoimmune Disease
2.5.3 Acute Infection
2.5.4 Others
2.5.5 Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
2.5.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2021-2026)
2.5.5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Breakdown Data by Company
3.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Company (2021-2026)
3.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2021-2026)
3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2021-2026)
3.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2021-2026)
3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company
3.4 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.4 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.6 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
5 AMERICAS
5.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
5.1.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
5.1.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026)
5.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
5.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region
6.1.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026)
6.1.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2021-2026)
6.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
6.3 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous Immunoglobulin(IVIg) Therapy by Country
7.1.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
7.1.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026)
7.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
7.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.3 Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.4 Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
11.3 Intravenous Immunoglobulin(IVIg) Therapy Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
12.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Region
12.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Region (2027-2032)
12.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Type (2027-2032)
12.7 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.1.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.2.3 CSL Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.3.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.4.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.5.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 LFB Group
13.6.1 LFB Group Company Information
13.6.2 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.6.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 LFB Group Main Business Overview
13.6.5 LFB Group Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.7.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 BPL
13.8.1 BPL Company Information
13.8.2 BPL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.8.3 BPL Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BPL Main Business Overview
13.8.5 BPL Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.9.3 RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.10.3 CBPO Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 Hualan Bio
13.11.1 Hualan Bio Company Information
13.11.2 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.11.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hualan Bio Main Business Overview
13.11.5 Hualan Bio Latest Developments
13.12 Tiantan Bio
13.12.1 Tiantan Bio Company Information
13.12.2 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.12.3 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tiantan Bio Main Business Overview
13.12.5 Tiantan Bio Latest Developments
13.13 Shuanglin Bio
13.13.1 Shuanglin Bio Company Information
13.13.2 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.13.3 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shuanglin Bio Main Business Overview
13.13.5 Shuanglin Bio Latest Developments
13.14 Boya Bio
13.14.1 Boya Bio Company Information
13.14.2 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.14.3 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Boya Bio Main Business Overview
13.14.5 Boya Bio Latest Developments
13.15 Yuanda Shuyang
13.15.1 Yuanda Shuyang Company Information
13.15.2 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.15.3 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Yuanda Shuyang Main Business Overview
13.15.5 Yuanda Shuyang Latest Developments
13.16 Weiguang Bio
13.16.1 Weiguang Bio Company Information
13.16.2 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.16.3 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Weiguang Bio Main Business Overview
13.16.5 Weiguang Bio Latest Developments
13.17 Nanyue Bio
13.17.1 Nanyue Bio Company Information
13.17.2 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.17.3 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Nanyue Bio Main Business Overview
13.17.5 Nanyue Bio Latest Developments
13.18 KM Biologics
13.18.1 KM Biologics Company Information
13.18.2 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
13.18.3 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 KM Biologics Main Business Overview
13.18.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 6. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Table 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & ($ million)
Table 8. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2021-2026)
Table 9. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Low Concentration
Table 11. Major Players of Medium Concentration
Table 12. Major Players of High Concentration
Table 13. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Product Concentration (2021-2026) & (K Units)
Table 14. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Product Concentration (2021-2026)
Table 15. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Product Concentration (2021-2026) & ($ million)
Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Product Concentration (2021-2026)
Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Product Concentration (2021-2026) & (US$/Unit)
Table 18. Major Players of Acute Therapy
Table 19. Major Players of Maintenance Therapy
Table 20. Major Players of Critical Care
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Treatment Setting (2021-2026) & (K Units)
Table 22. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Treatment Setting (2021-2026)
Table 23. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Treatment Setting (2021-2026) & ($ million)
Table 24. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Treatment Setting (2021-2026)
Table 25. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Treatment Setting (2021-2026) & (US$/Unit)
Table 26. Global Intravenous Immunoglobulin(IVIg) Therapy Sale by Application (2021-2026) & (K Units)
Table 27. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2021-2026)
Table 28. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & ($ million)
Table 29. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2021-2026)
Table 30. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Company (2021-2026) & (K Units)
Table 32. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2021-2026)
Table 33. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2021-2026)
Table 35. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution and Sales Area
Table 37. Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
Table 38. Intravenous Immunoglobulin(IVIg) Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Geographic Region (2021-2026)
Table 43. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2021-2026)
Table 47. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units)
Table 50. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026)
Table 51. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 53. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 54. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026) & (K Units)
Table 55. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2021-2026)
Table 56. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 58. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 59. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units)
Table 60. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 62. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Intravenous Immunoglobulin(IVIg) Therapy
Table 68. Key Market Challenges & Risks of Intravenous Immunoglobulin(IVIg) Therapy
Table 69. Key Industry Trends of Intravenous Immunoglobulin(IVIg) Therapy
Table 70. Intravenous Immunoglobulin(IVIg) Therapy Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Intravenous Immunoglobulin(IVIg) Therapy Distributors List
Table 73. Intravenous Immunoglobulin(IVIg) Therapy Customer List
Table 74. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Takeda Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 90. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Takeda Main Business
Table 92. Takeda Latest Developments
Table 93. CSL Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. CSL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 95. CSL Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. CSL Main Business
Table 97. CSL Latest Developments
Table 98. Grifols Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 100. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Grifols Main Business
Table 102. Grifols Latest Developments
Table 103. Octapharma Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 105. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Octapharma Main Business
Table 107. Octapharma Latest Developments
Table 108. Kedrion Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 110. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Kedrion Main Business
Table 112. Kedrion Latest Developments
Table 113. LFB Group Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 115. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. LFB Group Main Business
Table 117. LFB Group Latest Developments
Table 118. Biotest Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 119. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 120. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Biotest Main Business
Table 122. Biotest Latest Developments
Table 123. BPL Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 124. BPL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 125. BPL Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. BPL Main Business
Table 127. BPL Latest Developments
Table 128. RAAS Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 129. RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 130. RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. RAAS Main Business
Table 132. RAAS Latest Developments
Table 133. CBPO Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 134. CBPO Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 135. CBPO Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. CBPO Main Business
Table 137. CBPO Latest Developments
Table 138. Hualan Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 139. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 140. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Hualan Bio Main Business
Table 142. Hualan Bio Latest Developments
Table 143. Tiantan Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 144. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 145. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Tiantan Bio Main Business
Table 147. Tiantan Bio Latest Developments
Table 148. Shuanglin Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 149. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 150. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Shuanglin Bio Main Business
Table 152. Shuanglin Bio Latest Developments
Table 153. Boya Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 154. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 155. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Boya Bio Main Business
Table 157. Boya Bio Latest Developments
Table 158. Yuanda Shuyang Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 159. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 160. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Yuanda Shuyang Main Business
Table 162. Yuanda Shuyang Latest Developments
Table 163. Weiguang Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 164. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 165. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Weiguang Bio Main Business
Table 167. Weiguang Bio Latest Developments
Table 168. Nanyue Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 169. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 170. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Nanyue Bio Main Business
Table 172. Nanyue Bio Latest Developments
Table 173. KM Biologics Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 174. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 175. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. KM Biologics Main Business
Table 177. KM Biologics Latest Developments
Table 1. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 6. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Table 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & ($ million)
Table 8. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2021-2026)
Table 9. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Low Concentration
Table 11. Major Players of Medium Concentration
Table 12. Major Players of High Concentration
Table 13. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Product Concentration (2021-2026) & (K Units)
Table 14. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Product Concentration (2021-2026)
Table 15. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Product Concentration (2021-2026) & ($ million)
Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Product Concentration (2021-2026)
Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Product Concentration (2021-2026) & (US$/Unit)
Table 18. Major Players of Acute Therapy
Table 19. Major Players of Maintenance Therapy
Table 20. Major Players of Critical Care
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Treatment Setting (2021-2026) & (K Units)
Table 22. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Treatment Setting (2021-2026)
Table 23. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Treatment Setting (2021-2026) & ($ million)
Table 24. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Treatment Setting (2021-2026)
Table 25. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Treatment Setting (2021-2026) & (US$/Unit)
Table 26. Global Intravenous Immunoglobulin(IVIg) Therapy Sale by Application (2021-2026) & (K Units)
Table 27. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2021-2026)
Table 28. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & ($ million)
Table 29. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2021-2026)
Table 30. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Company (2021-2026) & (K Units)
Table 32. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2021-2026)
Table 33. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2021-2026)
Table 35. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution and Sales Area
Table 37. Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
Table 38. Intravenous Immunoglobulin(IVIg) Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Geographic Region (2021-2026)
Table 43. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2021-2026)
Table 47. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units)
Table 50. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026)
Table 51. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 53. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 54. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026) & (K Units)
Table 55. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2021-2026)
Table 56. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 58. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 59. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units)
Table 60. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 62. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Intravenous Immunoglobulin(IVIg) Therapy
Table 68. Key Market Challenges & Risks of Intravenous Immunoglobulin(IVIg) Therapy
Table 69. Key Industry Trends of Intravenous Immunoglobulin(IVIg) Therapy
Table 70. Intravenous Immunoglobulin(IVIg) Therapy Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Intravenous Immunoglobulin(IVIg) Therapy Distributors List
Table 73. Intravenous Immunoglobulin(IVIg) Therapy Customer List
Table 74. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Takeda Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 90. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Takeda Main Business
Table 92. Takeda Latest Developments
Table 93. CSL Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. CSL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 95. CSL Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. CSL Main Business
Table 97. CSL Latest Developments
Table 98. Grifols Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 100. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Grifols Main Business
Table 102. Grifols Latest Developments
Table 103. Octapharma Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 105. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Octapharma Main Business
Table 107. Octapharma Latest Developments
Table 108. Kedrion Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 110. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Kedrion Main Business
Table 112. Kedrion Latest Developments
Table 113. LFB Group Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 115. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. LFB Group Main Business
Table 117. LFB Group Latest Developments
Table 118. Biotest Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 119. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 120. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Biotest Main Business
Table 122. Biotest Latest Developments
Table 123. BPL Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 124. BPL Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 125. BPL Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. BPL Main Business
Table 127. BPL Latest Developments
Table 128. RAAS Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 129. RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 130. RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. RAAS Main Business
Table 132. RAAS Latest Developments
Table 133. CBPO Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 134. CBPO Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 135. CBPO Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. CBPO Main Business
Table 137. CBPO Latest Developments
Table 138. Hualan Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 139. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 140. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Hualan Bio Main Business
Table 142. Hualan Bio Latest Developments
Table 143. Tiantan Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 144. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 145. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Tiantan Bio Main Business
Table 147. Tiantan Bio Latest Developments
Table 148. Shuanglin Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 149. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 150. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Shuanglin Bio Main Business
Table 152. Shuanglin Bio Latest Developments
Table 153. Boya Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 154. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 155. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Boya Bio Main Business
Table 157. Boya Bio Latest Developments
Table 158. Yuanda Shuyang Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 159. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 160. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Yuanda Shuyang Main Business
Table 162. Yuanda Shuyang Latest Developments
Table 163. Weiguang Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 164. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 165. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Weiguang Bio Main Business
Table 167. Weiguang Bio Latest Developments
Table 168. Nanyue Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 169. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 170. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Nanyue Bio Main Business
Table 172. Nanyue Bio Latest Developments
Table 173. KM Biologics Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 174. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product Portfolios and Specifications
Table 175. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. KM Biologics Main Business
Table 177. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intravenous Immunoglobulin(IVIg) Therapy
Figure 2. Intravenous Immunoglobulin(IVIg) Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intravenous Immunoglobulin(IVIg) Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2025)
Figure 10. Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type in 2026
Figure 14. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Low Concentration
Figure 16. Product Picture of Medium Concentration
Figure 17. Product Picture of High Concentration
Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Product Concentration in 2026
Figure 19. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Product Concentration (2021-2026)
Figure 20. Product Picture of Acute Therapy
Figure 21. Product Picture of Maintenance Therapy
Figure 22. Product Picture of Critical Care
Figure 23. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Treatment Setting in 2026
Figure 24. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Treatment Setting (2021-2026)
Figure 25. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Immunodeficiency
Figure 26. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Immunodeficiency (2021-2026) & (K Units)
Figure 27. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Autoimmune Disease
Figure 28. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Autoimmune Disease (2021-2026) & (K Units)
Figure 29. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Acute Infection
Figure 30. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Acute Infection (2021-2026) & (K Units)
Figure 31. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Others
Figure 32. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Others (2021-2026) & (K Units)
Figure 33. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2025)
Figure 34. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application in 2025
Figure 35. Intravenous Immunoglobulin(IVIg) Therapy Sales by Company in 2025 (K Units)
Figure 36. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company in 2025
Figure 37. Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company in 2025 ($ millions)
Figure 38. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company in 2025
Figure 39. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 42. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 43. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 44. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 45. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 46. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 49. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2025
Figure 50. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2021-2026)
Figure 51. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 52. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 53. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region in 2025
Figure 58. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2021-2026)
Figure 59. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 60. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 61. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 65. India Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2025
Figure 69. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2021-2026)
Figure 70. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 71. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 72. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 73. France Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 80. Egypt Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy in 2026
Figure 86. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
Figure 87. Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
Figure 88. Channels of Distribution
Figure 89. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Forecast by Region (2027-2032)
Figure 90. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Intravenous Immunoglobulin(IVIg) Therapy
Figure 2. Intravenous Immunoglobulin(IVIg) Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intravenous Immunoglobulin(IVIg) Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2025)
Figure 10. Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type in 2026
Figure 14. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Low Concentration
Figure 16. Product Picture of Medium Concentration
Figure 17. Product Picture of High Concentration
Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Product Concentration in 2026
Figure 19. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Product Concentration (2021-2026)
Figure 20. Product Picture of Acute Therapy
Figure 21. Product Picture of Maintenance Therapy
Figure 22. Product Picture of Critical Care
Figure 23. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Treatment Setting in 2026
Figure 24. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Treatment Setting (2021-2026)
Figure 25. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Immunodeficiency
Figure 26. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Immunodeficiency (2021-2026) & (K Units)
Figure 27. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Autoimmune Disease
Figure 28. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Autoimmune Disease (2021-2026) & (K Units)
Figure 29. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Acute Infection
Figure 30. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Acute Infection (2021-2026) & (K Units)
Figure 31. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Others
Figure 32. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Others (2021-2026) & (K Units)
Figure 33. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2025)
Figure 34. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application in 2025
Figure 35. Intravenous Immunoglobulin(IVIg) Therapy Sales by Company in 2025 (K Units)
Figure 36. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company in 2025
Figure 37. Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company in 2025 ($ millions)
Figure 38. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company in 2025
Figure 39. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 42. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 43. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 44. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 45. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 46. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue 2021-2026 ($ millions)
Figure 49. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2025
Figure 50. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2021-2026)
Figure 51. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 52. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 53. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region in 2025
Figure 58. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2021-2026)
Figure 59. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 60. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 61. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 65. India Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2025
Figure 69. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2021-2026)
Figure 70. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 71. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 72. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 73. France Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026)
Figure 80. Egypt Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy in 2026
Figure 86. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
Figure 87. Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
Figure 88. Channels of Distribution
Figure 89. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Forecast by Region (2027-2032)
Figure 90. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Application (2027-2032)
